{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T07:58:22Z","timestamp":1789891102834,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":2261,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.breast.2013.07.010","type":"journal-article","created":{"date-parts":[[2013,9,27]],"date-time":"2013-09-27T13:57:56Z","timestamp":1380290276000},"page":"S50-S56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"S2","title":["The metastatic microenvironment of breast cancer: Clinical implications"],"prefix":"10.1016","volume":"22","author":[{"given":"R.E.","family":"Coleman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Holen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2013.07.010_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10555-007-9106-7","article-title":"Using metastasis suppressor proteins to dissect interactions among cancer cells and their microenvironment","volume":"27","author":"Taylor","year":"2008","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.breast.2013.07.010_bib2","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1600-0463.2008.01027.x","article-title":"The role of metastasis suppressor genes in metastatic dormancy","volume":"116","author":"Horak","year":"2008","journal-title":"APMIS"},{"key":"10.1016\/j.breast.2013.07.010_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.gde.2007.12.006","article-title":"Microenvironmental regulation of cancer development","volume":"18","author":"Hu","year":"2008","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.breast.2013.07.010_bib4","first-page":"576","article-title":"New concepts in tissue-specific metastases","volume":"1","author":"Massague","year":"2003","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.breast.2013.07.010_bib5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1158\/1078-0432.CCR-11-2186","article-title":"Cancer dormancy: a model of early dissemination and late cancer recurrence","volume":"18","author":"P\u00e1ez","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.breast.2013.07.010_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1023\/A:1005887422022","article-title":"Estimate of tumor growth time for breast cancer local recurrences: rapid growth after wake-up?","volume":"51","author":"Demicheli","year":"1998","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2013.07.010_bib7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMoa050434","article-title":"A\u00a0pooled analysis of bone marrow micrometastasis in breast cancer","volume":"353","author":"Braun","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.breast.2013.07.010_bib8","first-page":"98","article-title":"The distribution of secondary growths in cancer of the breast","volume":"8","author":"Paget","year":"1889","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2013.07.010_bib9","article-title":"The niche under siege: novel targets for metastasis therapy","author":"Mart\u00ednez","year":"2012","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.breast.2013.07.010_bib10","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/jnci\/djs263","article-title":"Effects of bone-targeted agents on cancer progression and mortality","volume":"104","author":"Coleman","year":"2012","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2013.07.010_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bone.2011.02.003","article-title":"Bisphosphonates in oncology","volume":"49","author":"Coleman","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.breast.2013.07.010_bib12","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/jnci\/djn240","article-title":"Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer","volume":"100","author":"Ottewell","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2013.07.010_bib13","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.yexcr.2009.03.003","article-title":"Extracellular calcium promotes the migration of breast cancer cells through the activation of the calcium sensing receptor","volume":"315","author":"Saidak","year":"2009","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.breast.2013.07.010_bib14","first-page":"97","article-title":"Tracking the seed and tending the soil: evolving concepts in metastatic breast cancer","volume":"14","author":"Comen","year":"2012","journal-title":"Discov Med"},{"key":"10.1016\/j.breast.2013.07.010_bib15","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.cell.2009.11.025","article-title":"Tumour self-seeding by circulating cancer cells","volume":"139","author":"Kim","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.breast.2013.07.010_bib16","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/cncr.11132","article-title":"Mechanisms of osteolytic bone metastases in breast carcinoma","volume":"97","author":"K\u00e4k\u00f6nen","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2013.07.010_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2220\/biomedres.26.159","article-title":"Histological observations on the microenvironment of osteolytic bone metastasis by breast carcinoma cell line","volume":"26","author":"Shimamura","year":"2005","journal-title":"Biomed Res"},{"key":"10.1016\/j.breast.2013.07.010_bib18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc3055","article-title":"Cancer to bone: a fatal attraction","volume":"11","author":"Weilbaecher","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.breast.2013.07.010_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(11)61226-9","article-title":"Denosumab and bone metastasis-free survival in men with castration-resistant prostate cancer: results of a global phase 3, randomised, placebo-controlled trial","volume":"379","author":"Smith","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2013.07.010_bib20","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1177\/009127002762491316","article-title":"Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases","volume":"42","author":"Chen","year":"2002","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.breast.2013.07.010_bib21","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1158\/1078-0432.CCR-07-0247","article-title":"Prolonged efficacy of a single dose of the bisphosphonate zoledronic acid","volume":"13","author":"Brown","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.breast.2013.07.010_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bone.2010.11.008","article-title":"Biochemical and molecular mechanisms of action of bisphosphonates","volume":"49","author":"Rogers","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.breast.2013.07.010_bib23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s12094-011-0634-9","article-title":"Direct antitumour activity of zoledronic acid: preclinical and clinical data","volume":"13","author":"Bosch-Barrera","year":"2011","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.breast.2013.07.010_bib24","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ijc.24756","article-title":"Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model","volume":"126","author":"Ottewell","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.breast.2013.07.010_bib25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/bcr2769","article-title":"Anti-tumour activity of bisphosphonates in preclinical models of breast cancer","volume":"12","author":"Holen","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.breast.2013.07.010_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bone.2010.09.035","article-title":"Nitrogen-containing bisphosphonates can inhibit angiogenesis in\u00a0vivo without the involvement of farnesyl pyrophosphate synthase","volume":"48","author":"Stresing","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.breast.2013.07.010_bib27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1479-5876-9-177","article-title":"Tumour macrophages as potential targets of bisphosphonates","volume":"9","author":"Rogers","year":"2011","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.breast.2013.07.010_bib28","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/jnci\/djk054","article-title":"Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis","volume":"99","author":"Daubin\u00e9","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2013.07.010_bib29","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/sj.bjc.6605604","article-title":"The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer","volume":"102","author":"Coleman","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.breast.2013.07.010_bib30","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1158\/1078-0432.CCR-12-3235","article-title":"Neoadjuvant chemotherapy with or without zoledronic acid in early breast cancer \u2013 a randomised pilot study evaluating biomarkers","volume":"19","author":"Winter","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.breast.2013.07.010_bib31","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1470-2045(10)70054-1","article-title":"Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial","volume":"11","author":"Aft","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2013.07.010_bib32","first-page":"1807","article-title":"Effect of zoledronic acid on persisting isolated tumour cells in patients with early breast cancer","volume":"30","author":"Rack","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.breast.2013.07.010_bib33","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1093\/annonc\/mdr612","article-title":"Influence of zoledronic acid on disseminated tumour cells in primary breast cancer patients","volume":"23","author":"Solomayer","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2013.07.010_bib34","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa0806285","article-title":"Endocrine therapy plus zoledronic acid in premenopausal breast cancer","volume":"360","author":"Gnant","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"24Suppl.","key":"10.1016\/j.breast.2013.07.010_bib35","article-title":"Long-term follow-up in ABCSG-12: significantly improved overall survival with adjuvant zoledronic acid in premenopausal patients with endocrine-receptor-positive early breast cancer","volume":"71","author":"Gnant","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.breast.2013.07.010_bib36","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1105195","article-title":"Breast-cancer adjuvant therapy with zoledronic acid","volume":"365","author":"Coleman","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.breast.2013.07.010_bib37","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/annonc\/mds277","article-title":"Zoledronic acid (zoledronate) for\u00a0postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results","volume":"24","author":"Coleman","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2013.07.010_bib38","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1470-2045(12)70226-7","article-title":"Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial","volume":"13","author":"Paterson","year":"2012","journal-title":"Lancet Oncol"},{"issue":"24 Suppl.","key":"10.1016\/j.breast.2013.07.010_bib39","volume":"71","author":"Mobus","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.breast.2013.07.010_bib40","doi-asserted-by":"crossref","DOI":"10.1186\/bcr1413","article-title":"Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer","volume":"8","author":"Powles","year":"2006","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.breast.2013.07.010_bib41","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ctrv.2012.02.007","article-title":"Seed, soil and secreted hormones: potential interactions of breast cancer cells with their endocrine\/paracrine microenvironment and implications for treatment with bisphosphonates","volume":"38","author":"Wilson","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.breast.2013.07.010_bib42","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1093\/annonc\/mds169","article-title":"The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis","volume":"23","author":"Hadji","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2013.07.010_bib43","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.molmed.2006.01.006","article-title":"Circulating tumor cells: the \u2018leukemic phase\u2019 of solid cancers","volume":"12","author":"Mocellin","year":"2006","journal-title":"Trends Mol Med"},{"issue":"suppl.","key":"10.1016\/j.breast.2013.07.010_bib44","article-title":"Adjuvant zoledronic acid (ZOL) in postmenopausal women with breast cancer and those rendered postmenopausal: results of a meta-analysis","volume":"30","author":"Gregory","year":"2012","journal-title":"J\u00a0Clin Oncol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977613001458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977613001458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:30:11Z","timestamp":1760776211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977613001458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":44,"alternative-id":["S0960977613001458"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2013.07.010","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The metastatic microenvironment of breast cancer: Clinical implications","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2013.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}